Correlation Between Vaccinex and NLS Pharmaceutics
Can any of the company-specific risk be diversified away by investing in both Vaccinex and NLS Pharmaceutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vaccinex and NLS Pharmaceutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vaccinex and NLS Pharmaceutics AG, you can compare the effects of market volatilities on Vaccinex and NLS Pharmaceutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vaccinex with a short position of NLS Pharmaceutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vaccinex and NLS Pharmaceutics.
Diversification Opportunities for Vaccinex and NLS Pharmaceutics
0.54 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Vaccinex and NLS is 0.54. Overlapping area represents the amount of risk that can be diversified away by holding Vaccinex and NLS Pharmaceutics AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NLS Pharmaceutics and Vaccinex is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vaccinex are associated (or correlated) with NLS Pharmaceutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NLS Pharmaceutics has no effect on the direction of Vaccinex i.e., Vaccinex and NLS Pharmaceutics go up and down completely randomly.
Pair Corralation between Vaccinex and NLS Pharmaceutics
Given the investment horizon of 90 days Vaccinex is expected to generate 1.41 times more return on investment than NLS Pharmaceutics. However, Vaccinex is 1.41 times more volatile than NLS Pharmaceutics AG. It trades about 0.08 of its potential returns per unit of risk. NLS Pharmaceutics AG is currently generating about -0.12 per unit of risk. If you would invest 339.00 in Vaccinex on August 25, 2024 and sell it today you would earn a total of 23.00 from holding Vaccinex or generate 6.78% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Vaccinex vs. NLS Pharmaceutics AG
Performance |
| Timeline |
| Vaccinex |
| NLS Pharmaceutics |
Vaccinex and NLS Pharmaceutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Vaccinex and NLS Pharmaceutics
The main advantage of trading using opposite Vaccinex and NLS Pharmaceutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vaccinex position performs unexpectedly, NLS Pharmaceutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NLS Pharmaceutics will offset losses from the drop in NLS Pharmaceutics' long position.| Vaccinex vs. Eliem Therapeutics | Vaccinex vs. HCW Biologics | Vaccinex vs. RenovoRx | Vaccinex vs. Scpharmaceuticals |
| NLS Pharmaceutics vs. Neurobo Pharmaceuticals | NLS Pharmaceutics vs. Indaptus Therapeutics | NLS Pharmaceutics vs. Pasithea Therapeutics Corp | NLS Pharmaceutics vs. Quoin Pharmaceuticals Ltd |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Other Complementary Tools
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |